Table 2.
Resistant and susceptible phenotypes | Erythromycin | Clindamycin | D test | Total S. aureus (n = 76) | MRSA (n = 36) | MSSA (n = 40) |
---|---|---|---|---|---|---|
Inducible MLSB | R | S | + | 17 (22.4%) | 15 (41.7%) | 2 (5%) |
Constitutive MLSB | R | R | – | 8 (10.5%) | 4 (11.1%) | 4 (10%) |
MSB | R | S | – | 17 (22.4%) | 7 (19.4%) | 10 (25%) |
Susceptible | S | S | – | 34 (44.7%) | 10 (27.8%) | 24 (60%) |
MLS B macrolide–lincosamide–streptogramin B, MS B macrolide–streptogramin B